COVID-19 INFORMATION Learn More

Infusion Center

Your Needs Matter Here

We provide infusion therapy (IV) services in a friendly, healing environment. We treat patients with blood disorders, cancer, Crohn’s disease, dehydration, migraines, osteoporosis, rheumatoid arthritis, and other acute or chronic illnesses.

Visiting an infusion center for the first time can be intimidating. Rest assured that you will be treated with care here. Our friendly and compassionate staff will guide you through the infusion process and make sure you have everything you need to remain comfortable during treatment. With comfortable recliners, televisions, books, magazines, snacks, and refreshments we are dedicated to making your visit a pleasant experience. Your needs matter here.

Specialty Trained Staff

Our highly skilled, experienced nurses have specialized training in infusion therapy and oncology care, to provide a range of therapies and close monitoring to ensure safety including:

  • Antibiotic Therapy
  • Biotherapy Targeted Treatment
  • Blood Transfusions
  • Chemotherapy
  • Immunotherapy
  • Intravenous therapy (IV)
  • Iron Treatment
  • Injections
  • PICC (peripheral inserted central line) and implanted port care

Treatment Close to Home

We understand the importance of receiving quality care and treatment close to home. We provide services in many communities:

Medical Oncology affiliate sites:

Certain complex medications need to be accessed by specialty trained providers and can only be given at Coborn Cancer Center.

Scalp Cooling Now Available

Men and women receiving chemotherapy treatment for certain cancers at Coborn Cancer Center can now keep control of their hair loss by using a ground-breaking scalp cooling treatment. The Paxman Scalp Cooling System helps reduce hair loss throughout chemotherapy. It works by reducing the temperature of the scalp by a few degrees immediately before, during, and after the administration of chemotherapy.

For anyone who wants to go ahead with scalp cooling, www.PaxmanUSA.com features an online resource area designed to make the whole process as easy as possible. If you need help to pay for Paxman Scalp Cooling, don’t worry, as help is at hand. Scholarships for scalp cooling are available from CentraCare Health Foundation. Another option is Hair To Stay, a national non-profit subsidizing scalp cooling patients in the United States. You can apply for a subsidy to help you access Paxman scalp cooling treatment by contacting the Paxman Hub. A case manager will guide you through the eligibility process. Visit www.hairtostay.org

Find out more at www.PaxmanUSA.com

Recent Cancer Care Articles: See All Cancer Care Articles

Dear Friends and Neighbors,

CentraCare care givers have been working around the clock for more than 20 months to care for you, your families and friends during COVID. We are committed to caring for every Minnesotan who needs us, and nothing will prevent us from doing so – even during these never-seen-before times.

The challenge of providing this level of care is that our hospital beds are often full. ERs in all of our hospitals are packed. And our clinical teams are exhausted. Early in the pandemic, our community stepped up in amazing ways to help us. We ask that you again join us in fighting this pandemic together.

How can you help?

  • Please get your COVID vaccines and booster shots. They are proven safe and effective in reducing COVID illness, keeping people out of the hospital, and preventing death.
  • If your situation is not an emergency, please use other care options, including:
  • If this is a medical emergency, call 9-1-1, or visit the ER.

Together, we can do this. Thank you for your support.

Ken Holmen, MD
President and CEO

Featured Patient Story

Lymphoma: Raine's Story Infusion Center Patient Story
"I was lucky enough to develop a condition that led to a required colonoscopy. I wasn’t yet fifty and wouldn’t have elected to get one. However, that led to early detection of my cancer and I believe saved my life. There is no reason to wait or put it off."
Read Full Story